Cargando…
The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer
Aberrant activation of Ras/Raf/mitogen-activated protein kinase (MAPK) signaling is frequently linked to metastatic prostate cancer (PCa); therefore, the characterization of modulators of this pathway is critical for defining therapeutic vulnerabilities for metastatic PCa. The lysine methyltransfera...
Autores principales: | Ikram, Sabeen, Rege, Apurv, Negesse, Maraki Y., Casanova, Alexandre G., Reynoird, Nicolas, Green, Erin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656069/ https://www.ncbi.nlm.nih.gov/pubmed/37976356 http://dx.doi.org/10.1126/sciadv.adi5921 |
Ejemplares similares
-
SMYD2 inhibition–mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity
por: Tang, Ming, et al.
Publicado: (2023) -
Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis
por: Hsu, Pei-Ling, et al.
Publicado: (2023) -
A histone deacetylase 3 and mitochondrial complex I axis regulates toxic formaldehyde production
por: Wit, Niek, et al.
Publicado: (2023) -
ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancers
por: Mooz, Juliane, et al.
Publicado: (2022) -
Widespread hypertranscription in aggressive human cancers
por: Zatzman, Matthew, et al.
Publicado: (2022)